Subcommittee Hearing: Taking Measure of Countermeasures (Part 1)

Subcommittee on Emergency Preparedness, Response, and Communications | 311 Cannon House Office Building Washington, DC 20008 | Apr 13, 2011 2:00pm

On Wednesday, April 13, 2011 the Committee on Homeland Security’s Subcommittee on Emergency Preparedness, Response, and Communications will hold a hearing entitled “Taking Measure of Countermeasures (Part 1):  A review of government and industry efforts to protect the homeland through accelerated research, development, and acquisition of chemical, biological, radiological and nuclear medical countermeasures.”  The Committee will meet at 2:00 p.m. in 311 Cannon House Office Building.

Opening Statements

Rep. Gus M. Bilirakis, Chairman

[full text of opening statement]

Witnesses

Panel 1

Ms. Cynthia Bascetta, Managing Director, Health Care, Government Accountability Office
[full text of testimony]
 
Dr. Segaran P. Pillai, Chief Medical and Science Advisor, Chemical and Biological Division, Science and Technology Directorate, Department of Homeland Security
[full text of testimony]

Dr. Richard J. Hatchett, Chief Medical Officer and Deputy Director, Strategic Sciences and Management, Department of Health and Human Services
[full text of testimony]

Dr. Gerald W. Parker, Deputy Assistant to the Secretary of Defense, Chemical and Biological Defense, Department of Defense
[full text of testimony]
 
PANEL 2

Ms. Phyllis Arthur, Senior Director, Vaccines, Immunotherapeutics, and Diagnostics Policy, Biotechnology Industry Organization
[full text of testimony]
[truth in testimony]

Mr. John M. Clerici, Principal, Tiber Creek Partners LLC
[full text of testimony]
[truth in testimony]

Dr. Daniel Fagbuyi, Medical Director, Disaster Preparedness and Emergency Management, Children’s National Medical Center
[full text of testimony]
[truth in testimony]